1. Authors' reply to Agarwal et al. and Iyer
   Ajeet Kumar Gandhi et al, 2022, Cancer Research, Statistics, and Treatment CrossRef
2. Post(neo)adjuvante Therapiekonzepte – Möglichkeiten der Therapieoptimierung
   Natalia Krawczyk et al, 2022, Der Gynäkologe CrossRef
3. Based on network pharmacology and molecular docking to explore the protective effect of Epimedii Folium extract on cisplatin-induced intestinal injury in mice
   Juan Xia et al, 2022, Frontiers in Pharmacology CrossRef
4. Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
   Ali Miri et al, 2023, Frontiers in Oncology CrossRef
5. Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments
   Edgardo S. Santos et al, 2024, JCO Oncology Practice CrossRef
6. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies
   Aleksandra Romaniuk-Drapała et al, 2024, Cancers CrossRef
7. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis
   Courtney E. McAleese et al, 2022, Breast Cancer Research and Treatment CrossRef
8. Mind over chronic pain: A meta-analysis of cognitive restructuring in chronically ill adults
   Sebastian Pintea et al, 2024, Journal of Psychosomatic Research CrossRef
9. Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
   Nating Xiong et al, 2024, Frontiers in Oncology CrossRef